{"title": "", "body": "Nous proposons compte-tenu de l'urgence sanitaire une adaptation des recommandations th\u00e9rapeutiques. \n\nRegarding the COVID-19 outbreak, we propose an adaptation of current recommendations for clinical practice.\n\nPatients with suspected COVID-19 should be screened for the presence of the virus. If confirmed or highly suspected (clinically or CT-scan), any treatment must be postponed at least 15 days after the start of the symptoms and when the patient has recovered.\n\nMultidisciplinary tumor boards remain at your disposition for virtual discussion.\n\nContact the manager of your local MDT.\n\n\uf0b7\uf020\n\nfor patients without of COVID-19 symptoms.\n\nDo not delay surgery for operable patients without COVID symptoms:\n\nGrade 2-3 soft tissue sarcoma, bone sarcoma, GIST and visceral sarcoma.\n\nIn the case of high-risk surgery (retroperitoneal sarcoma): ensure postoperative resuscitation capacities.\n\nRadiation therapy for soft tissue sarcoma should not be delayed.\n\nFor soft tissue sarcoma, neo-adjuvant chemotherapy should be reserved for patients who are inoperable or in whom the only possible intervention is mutilating. Also discuss preoperative radiotherapy, depending on location and histological type. "}